Hypera Sa Stock Today
| HYPMY Stock | USD 3.36 0.18 5.66% |
PerformanceOK
| Odds Of DistressLow
|
Hypera SA is trading at 3.36 as of the 17th of March 2025; that is 5.66% up since the beginning of the trading day. The stock's open price was 3.18. Hypera SA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company has 631.94 M outstanding shares. More on Hypera SA
Moving together with Hypera Pink Sheet
| 0.65 | TAK | Takeda Pharmaceutical Sell-off Trend | PairCorr |
Moving against Hypera Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hypera Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Hypera SA [HYPMY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.55 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hypera SA's market, we take the total number of its shares issued and multiply it by Hypera SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hypera SA classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 631.94 M outstanding shares.
Hypera SA has accumulated about 1.5 B in cash with 1.4 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37.
Check Hypera SA Probability Of Bankruptcy
Ownership AllocationHypera SA has a total of 631.94 Million outstanding shares. Roughly 99.97 (percent) of Hypera SA outstanding shares are held by general public with 0.03 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hypera Ownership Details
Hypera SA Risk Profiles
| Mean Deviation | 1.78 | |||
| Semi Deviation | 1.95 | |||
| Standard Deviation | 2.47 | |||
| Variance | 6.1 |
Hypera Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hypera SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Hypera SA Corporate Management
| Adalmario Couto | Investor CFO | Profile | |
| Juliana Salem | Legal Officer | Profile | |
| Hlio Segouras | Head Health | Profile | |
| Joao Aguilar | Risks Officer | Profile | |
| Mauricio Christovam | HR Officer | Profile | |
| Nelson Mello | Institutional Relations Officer, Member of the Executive Board | Profile |
Additional Tools for Hypera Pink Sheet Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.